Serum HER-2 Levels as a Predictor of Clinical Outcome in Metastatic Breast Cancer (MBC) Patients Treated with Trastuzumab-Based Therapies
Saved in:
Published in | Annals of oncology Vol. 24; p. iii29 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
01.05.2013
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0923-7534 |
---|---|
DOI: | 10.1093/annonc/mdt084.13 |